Keele Research Repository
Explore the Repository
Hinton, J, Augustine, M, Gabara, L, Mariathas, M, Allan, R, Borca, F, Nicholas, Z, Gillett, N, Kwok, CS, Cook, P, Grocott, MPW, Mamas, MA and Curzen, N (2023) Is high sensitivity troponin, taken regardless of a clinical indication, associated with 1 year mortality in critical care patients? Journal of the Intensive Care Society. ISSN 1751-1437
Full text not available from this repository.Abstract
The aim of this study was to assess whether high sensitivity troponin (hs-cTnI) is associated with 1 year mortality in critical care (CC). One year mortality data were obtained from NHS Digital for a consecutive cohort of patients admitted to general CC unit (GCCU) and neuroscience CC unit (NCCU) who had hs-cTnI tests performed throughout their CC admission, regardless of whether the test was clinically indicated. Cox proportional hazards were used to estimate the risk of 1-year mortality. A landmark analysis was undertaken to assess whether any relationship at 1 year was driven by mortality within the first 30 days. A total of 1033 consecutive patients were included. At 1 year 254 (24.6%) patients had died. The admission log(10)hs-cTnI concentration in the entire cohort (HR 1.35 (95% CI 1.05–1.75) p = 0.009 with a bootstrap of 1000 samples) was independently associated with 1 year mortality. On landmark analysis the association with 1 year mortality was driven by 30 day mortality. These results indicate that admission hs-cTnI concentration is independently associated with 1 year mortality in CC and this relationship may be driven by differences in mortality at 30 days.
Item Type: | Article |
---|---|
Additional Information: | The final version of this article and all relevant information related to it, including copyrights, can be found on the publisher website. |
Subjects: | R Medicine > R Medicine (General) |
Depositing User: | Symplectic |
Date Deposited: | 04 May 2023 08:27 |
Last Modified: | 04 May 2023 08:27 |
URI: | https://eprints.keele.ac.uk/id/eprint/12356 |